| Page 26 | Cafepharma

You are here

Primary tabs

CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid

Post date: April 9, 2018 - 9:42am

BioCardia PH III CardiAMP Heart Failure Trial Discussed in American Heart Journal

Post date: April 9, 2018 - 9:13am

Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer

Post date: April 6, 2018 - 2:41pm

EyeGate Receives Milestone Payment for Completion of Enrollment in Ph III Study in Anterior Uveitis

Post date: April 6, 2018 - 9:42am

Immunotherapy Combination Trial in Metastatic Lung Cancer Shows Promise of Success

Post date: April 5, 2018 - 11:40pm

Visiongate Announces Next Step in Commercialization of Cancer Detection Platform

Post date: April 5, 2018 - 7:39pm

Intercept Pharmaceuticals Announces Pricing of Upsized $250 Million Public Offering and Concurrent Private Placement of Common Stock

Post date: April 5, 2018 - 3:50pm

Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers

Post date: April 5, 2018 - 9:12am

QurAlis Announces New Investors to Help Fund Drive to Cure ALS

Post date: April 5, 2018 - 8:46am

FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND

Post date: April 5, 2018 - 8:28am

Pages